Monthly Archives: November 2011
Screening Study for Ovarian Cancer
A new study of 545 women with a family history of ovarian cancer were provided annual screening with the CA-125 blood test and transvaginal ultrasound. This interval of testing with these tools did not find any early stage ovarian cancers. Read … Continue reading
Women’s Sexuality Altered by Diagnosis of Ovarian Cancer
A small focus group of women with ovarian cancer indicated that “Regardless of age, women reported that ovarian cancer treatment had a detrimental impact on their sexuality and that the changes made them feel ‘no longer whole.’” The article called … Continue reading
Posted in News Tagged quality of life, Research, side effects, support, survivorship Leave a comment
Your Cyber Monday Shopping Can Help Women with Ovarian Cancer
Are you eagerly awaiting the online shopping deals on Cyber Monday? Make your holiday giving go further with the Ovarian Cancer National Alliance Shopping Mall. Hundreds of popular retailers will donate to our programs if you shop through the links … Continue reading
Posted in Blog Leave a comment
2011.11.21 Ovarian Cancer Advocates Support Broad Access to Oral Contraceptives as Preventive Medicine; Oppose Broadening of Religious Exemptions
Washington, DC—In July 2011, the Department of Health and Human Services adopted recommendations on services that would be covered with no co-pay for women under the Affordable Care Act, including oral contraceptives. The Ovarian Cancer National Alliance praised that decision, … Continue reading
Posted in News, Press Releases Leave a comment
2011.11.18 Ovarian Cancer Advocates Troubled by FDA Decision on Avastin and Breast Cancer
Washington, DC—Today the Food and Drug Administration (FDA) announced that it would remove metastatic breast cancer from the label for Avastin (bevacizumab). This decision follows recommendations made in June by the FDA Oncologic Drugs Advisory Committee. Responding to today’s decision, … Continue reading
Posted in News, Press Releases Leave a comment
Insurance loophole on cancer treatments sticks patients with extreme cost
November 16, 2011 Washington Post Nobody likes paying a lot for health insurance, but at least it provides peace of mind. Even while we grumble about steadily rising deductibles and co-pays, we figure if we get really sick — with … Continue reading
Posted in News Leave a comment
Partner Member Profile: Georgia Ovarian Cancer Alliance
The Georgia Ovarian Cancer Alliance got its start in 1998, when 13 survivors met. “They saw that there was a lot of work being done around research and testing,” says Doug Barron, Executive Director of the group. “But there was … Continue reading
Posted in Blog Leave a comment
Drug Shortages: Status and Next Steps Webinar
In 2011, the United States experienced shortages of more than 200 drugs, including chemotherapeutic agents, intravenous nutrition and anesthesia drugs. The vast majority of drugs in shortage were generic sterile injectibles. Many ovarian cancer patients are wondering what is being … Continue reading
Posted in Events Leave a comment
HE4 May be Helpful in Screening
Neoadjuvant Chemotherapy: The Debate Continues
Two articles in the Journal of Clinical Oncology debate the use of neoadjuvant chemotherapy – chemo given before surgery – for ovarian cancer patients. Based on some studies, researchers conclude that neoadjuvant chemotherapy may be the best option for some … Continue reading
